Investors

Two people discussing in a meeting room with a laptop displaying a presentation titled 'Drug Delivery. Reimagined' and an image of a microscopic view of a drug molecule; there are papers, graphs, a calculator, a tablet, and a mug on the table.

REVIUM RX
(NASDAQ OTC: RVRC)

ReviumRx is a preclinical biotechnology company developing next-generation, lipid-based therapies to address some of the most pressing challenges in medicine.

Management
Board of Directors
Scientific Advisory Board

Latest news

Financial Update

Annual report

Annual report 2024

Quarterly Reports

Q2 2025
Q1 2025
Q3 2024
Q2 2024